Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series (Q48105623)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

Alan Luiz Eckeli

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

author name string

M H N Chagas

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

A W Zuardi

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

M A Pena-Pereira

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

M A Sobreira-Neto

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

E T Sobreira

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

M R Camilo

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

M M Bergamaschi

8

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

C H Schenck

9

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

J E C Hallak

10

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

V Tumas

11

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

J A S Crippa

12

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

publication date

21 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

39

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

564-566

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Treatment outcomes in REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Cannabidiol for the treatment of psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Hypnoticlike effects of cannabidiol in the rat

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Anandamide modulates sleep and memory in rats

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Treatment of REM sleep behavior disorder with donepezil: a report of three cases

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

1 reference

https://api.crossref.org/works/10.1111/JCPT.12179

21 January 2018

Identifiers

10.1111/JCPT.12179

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24845114

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48105623&oldid=2184899496"